Email Newsletters

Life Sciences

Kevin A. Gray, Chief Technology Officer, Qteros Inc.

In its quest to bring new biofuel technology to market, Qteros of Marlborough recently hired Kevin Gray...

Genzyme Closes Drug Deal With Bayer

Cambridge-based Genzyme Corp., which has significant operations in Central Massachusetts, has completed its acquisition of a multiple...

Sepracor Drug Under FDA Review

A new seizure medication under development by Marlborough-based Sepracor Inc. is now under formal review by the...

May 25, 2009 Issue of the WBJ

Watch as WBJ Editor Christina Davis talks about what you'll find in the May 25 issue of...
ADVERTISEMENT

Med School Gets China Syndrome

Worcester biotech and medical researchers pride themselves on their collaborative work, and on May 8 some of...

RXi Q1 Loss Up As Expenses Rise

RXi Pharmaceuticals Inc. of Worcester increased its first-quarter loss 57 percent this year as it ramped up...

Research: Drug Sales Flat Into 2015

Drug sales for the world's top 10 pharmaceutical companies slowed significantly in 2008, according to Waltham-based Decision...

Acton Co. President Joins Vaccine Maker Board

Howard L. Levine, president of BioProcess Technology Consultants Inc. in Acton, has joined the board of directors...
ADVERTISEMENT

ACT Files Past-Due Reports With SEC

Worcester-based Advanced Cell Technology Inc. reported net losses of $5.6 million and $12.6 million for the second...

Hidden Scientific Research At Worcester State

People are used to hearing about research with the potential to cure or mitigate some of life’s...
ADVERTISEMENT

Latest Stories

More Business News
ADVERTISEMENT

Thought Leadership

More Thought Leadership

Career Opportunities

More Jobs | Submit a Job

Upcoming Events

More Events | Submit an Event

December Flash Sale! Get 40% off new subscriptions from now until December 19th!

Close the CTA

Get our email newsletter

Stay up-to-date on the companies, people and issues that impact businesses in Central Massachusetts.

Close the CTA